Through its Contract Manufacturing Organization (CMO) structure, BiotechTown will offer a production structure for companies that need support and a licensed & certified area in the development of pilot batches and commercial batches, minimizing costs and allowing greater agility to bring products to the marketplace.
The CMO is designed for high-performance production, offering services in an exclusive and customized way, with established standards of information security and intellectual property.
BiotechTown’s CMO is in the process of being implemented, with completion scheduled for 2019. It will have 495m² of certified area, with infrastructure for providing services and production processes directed to companies of all sizes. The CMO will be aimed at health products, as defined by Anvisa: equipment, apparatus, material, article, system of use, medical, dental or laboratory application for prevention, diagnosis, treatment, rehabilitation or contraception and not using pharmacological, immune or metabolic means to perform its main function in humans, but may be aided in its functions by such means. With a full production line operated by the BiotechTown team and leased on demand, the CMO will adhere to the criteria of confidentiality, good practices and quality management.
Not yet widespread in Brazil, the concept of CMO is focused on the pharmaceutical sector and, due to an international trend, is moving towards other areas. The pioneer investment in such a structure, with a set of services focused on business scalability, meets the needs of companies of all sizes of Biotechnology and Life Sciences that need to create or expand part of their production process.
Watch the BiotechTown CMO video.